These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28328709)
1. The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium: Yttrium-Aluminum-Garnet Laser for the Treatment of Melasma and Solar Lentigenes in Asians: Prospective, Randomized, and Split-Face Comparative Study. Kaminaka C; Furukawa F; Yamamoto Y Dermatol Surg; 2017 Sep; 43(9):1120-1133. PubMed ID: 28328709 [TBL] [Abstract][Full Text] [Related]
2. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients. Yue B; Yang Q; Xu J; Lu Z Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275 [TBL] [Abstract][Full Text] [Related]
4. Commentary on The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium: Yttrium-Aluminum-Garnet Laser for the Treatment of Melasma and Solar Lentigenes in Asians. Kauvar ANB Dermatol Surg; 2017 Sep; 43(9):1134-1136. PubMed ID: 28661993 [No Abstract] [Full Text] [Related]
5. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Wattanakrai P; Mornchan R; Eimpunth S Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254 [TBL] [Abstract][Full Text] [Related]
6. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients. Choi JE; Lee DW; Seo SH; Ahn HH; Kye YC J Cosmet Dermatol; 2018 Dec; 17(6):1053-1058. PubMed ID: 30280474 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of dual-pulsed 1064 nm Q-switched Nd:YAG laser and single-pulsed 1064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma. Jang HW; Chun SH; Park HC; Ryu HJ; Kim IH J Cosmet Laser Ther; 2017 Apr; 19(2):114-123. PubMed ID: 27911108 [TBL] [Abstract][Full Text] [Related]
8. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women. Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361 [TBL] [Abstract][Full Text] [Related]
9. Q-Switched 660-nm Versus 532-nm Nd: YAG Laser for the Treatment for Facial Lentigines in Asian Patients: A Prospective, Randomized, Double-Blinded, Split-Face Comparison Pilot Study. Noh TK; Chung BY; Yeo UC; Chang S; Lee MW; Chang SE Dermatol Surg; 2015 Dec; 41(12):1389-95. PubMed ID: 26551773 [TBL] [Abstract][Full Text] [Related]
10. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma. Kar HK; Gupta L; Chauhan A Indian J Dermatol Venereol Leprol; 2012; 78(2):165-71. PubMed ID: 22421647 [TBL] [Abstract][Full Text] [Related]
11. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study. Zhou Y; Li Y; Hamblin MR; Wen X Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099 [TBL] [Abstract][Full Text] [Related]
12. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study. Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866 [TBL] [Abstract][Full Text] [Related]
13. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling. Vachiramon V; Sahawatwong S; Sirithanabadeekul P Dermatol Surg; 2015 Apr; 41(4):457-65. PubMed ID: 25760554 [TBL] [Abstract][Full Text] [Related]
14. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective? Gokalp H; Akkaya AD; Oram Y J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828 [TBL] [Abstract][Full Text] [Related]
15. Effect of spot size and fluence on Q-switched alexandrite laser treatment for pigmentation in Asians: a randomized, double-blinded, split-face comparative trial. Wang CC; Chen CK J Dermatolog Treat; 2012 Oct; 23(5):333-8. PubMed ID: 21756151 [TBL] [Abstract][Full Text] [Related]
16. Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser in patients with melasma aggravation after previous therapy. Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE J Cosmet Laser Ther; 2015 Jun; 17(3):129-34. PubMed ID: 25415369 [TBL] [Abstract][Full Text] [Related]
17. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV. Brown AS; Hussain M; Goldberg DJ J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of a novel dual--pulsed 1064 nm Q-switched Nd: YAG laser to treat Riehl's melanosis. Chung BY; Kim JE; Ko JY; Chang SE J Cosmet Laser Ther; 2014 Dec; 16(6):290-2. PubMed ID: 25046351 [TBL] [Abstract][Full Text] [Related]
19. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma. Park KY; Kim DH; Kim HK; Li K; Seo SJ; Hong CK Clin Exp Dermatol; 2011 Dec; 36(8):864-70. PubMed ID: 21973194 [TBL] [Abstract][Full Text] [Related]
20. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy. Ryu HJ; Kim J J Cosmet Laser Ther; 2013 Oct; 15(5):290-2. PubMed ID: 23464754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]